Logo image of ACRV

ACRIVON THERAPEUTICS INC (ACRV) Stock Analyst Ratings

NASDAQ:ACRV - Nasdaq - US0048901096 - Common Stock - Currency: USD

1.265  -0.07 (-4.89%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to ACRV. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 14.79. This target is 1069.17% above the current price.
ACRV was analyzed by 16 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ACRV.
In the previous month the buy percentage consensus was at a similar level.
ACRV was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
ACRV Historical Analyst RatingsACRV Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -28 -25 -22 -19 -16 -13 -10 -7 -4 -1 5 10 15

Price Target & Forecast

Price Low Median Mean High 1.277.0713.7714.7931.50 - 458.89% 988.54% 1,069.17% 2,390.12%
ACRV Current Analyst RatingACRV Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8
Up and Down Grades
Date Firm Action Rating
2025-03-28 HC Wainwright & Co. Reiterate Buy -> Buy
2025-03-26 Citizens Capital Markets Reiterate Market Outperform -> Market Outperform
2025-03-26 Cantor Fitzgerald Reiterate Overweight -> Overweight
2025-03-26 HC Wainwright & Co. Maintains Buy -> Buy
2025-01-31 Cantor Fitzgerald Initiate Overweight
2024-11-14 BMO Capital Maintains Outperform -> Outperform
2024-11-14 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-16 Ladenburg Thalmann Upgrade Neutral -> Buy
2024-09-16 BMO Capital Reiterate Outperform -> Outperform
2024-09-16 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-09-16 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-13 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-15 BMO Capital Reiterate Outperform -> Outperform
2024-05-14 HC Wainwright & Co. Maintains Buy -> Buy
2024-04-29 Ladenburg Thalmann Downgrade Buy -> Neutral
2024-04-26 BMO Capital Maintains Outperform -> Outperform
2024-04-25 JMP Securities Maintains Market Outperform -> Market Outperform
2024-04-25 Piper Sandler Maintains Overweight -> Overweight
2024-04-25 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-05 Ladenburg Thalmann Maintains Buy -> Buy
2024-04-01 BMO Capital Reiterate Outperform -> Outperform
2024-04-01 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-03-28 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-01 JMP Securities Initiate Market Outperform
2023-11-10 BMO Capital Maintains Outperform -> Outperform
2023-10-05 Maxim Group Initiate Buy
2023-09-06 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-18 JonesTrading Initiate Buy
2023-08-11 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-02 Oppenheimer Initiate Outperform